• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,949.08 -324.25
( -0.41%)
Global Indices
Nasdaq
49,166.17 -297.40
(-0.60%)
Dow Jones
7,084.21 -45.93
(-0.64%)
Hang Seng
59,361.39 536.50
(0.91%)
Nikkei 225
10,503.87 -105.21
(-0.99%)
Forex
USD-INR
92.99 0.41
(0.45%)
EUR-INR
109.45 0.58
(0.53%)
GBP-INR
125.69 0.62
(0.49%)
JPY-INR
0.59 0.00
(0.33%)

EQUITY - MARKET SCREENER

Medicamen Organics Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
92885
INE0PE401018
24.7648718
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MEDIORG
10.54
34.52
EPS(TTM)
Face Value()
Div & Yield %
2.8
10
0
 

L&T Finance climbs after strong retail disbursement in Q4
Apr 06,2026
The growth was supported by a 61.21% YoY rise in urban finance disbursements to Rs 9,840 crore and a 40.79% YoY growth in rural business finance to Rs 7,200 crore in Q4 FY26.

Retail loan book stood at Rs 1,19,550 crore in Q4 FY26, registering the growth of 26% compared with Rs 95,180 crore in Q4 FY25.

Realization improved to 98% in Q4 FY26 as against 97% in Q4 FY25.

On annual basis, the company’s retail disbursement increased 39% to Rs 83,190 crore in FY26 compared with Rs 60,040 crore in FY25.

L&T Finance is a leading non-banking financial company (NBFC), offering a range of financial products and services. The company has reported 18% rise in consolidated net profit to Rs 739 crore on a 18% increase in total income to Rs 2,920 crore in Q3 FY26 as compared with Q3 FY25.